This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
This article has been rated as Low-importance on the project's importance scale.
Incongruence of alleged autoreceptor activity with other well-studied models.
The sole source cited in this article alleges that SB-649,915 acts as a 5-HT autoreceptor antagonist, thereby inhibiting release of serotonin. Unless someone can find an article stating that 5-HT1 autoreceptors are atypical, then this assertion is entirely erroneous. Caffeine, an adenosine autoreceptor antagonist, works by inhibiting the detection of adenosine (ATP leftovers, in a way) and thereby increasing the homeostatic levels of adenosine, which in turn mildly stimulates most kinds of energetic cellular activity (activity that consumes ATP or any of its relative compounds). Under this well-studied logical paradigm, any typical autoreceptor antagonist would increase the homeostatic levels of the hormone whose autoreceptor is under blockade, not decrease. This is a logical flaw that should be corrected in the interest of correctness. — Preceding unsigned comment added by 188.8.131.52 (talk) 06:51, 23 February 2012 (UTC)